Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

42
Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology Security Forces Hospital Bleeding in early pregnancy and Ectopic Pregnancy

description

Bleeding in early pregnancy and Ectopic Pregnancy. Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology Security Forces Hospital. SPONTANEOUS ABORTION. Definition: - PowerPoint PPT Presentation

Transcript of Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Page 1: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Emad R. Sagr, MBBS, FRCSC, FACOG

Consultant OB-Gyn and Gynecology Oncology

Security Forces Hospital

Bleeding in early pregnancy and Ectopic

Pregnancy

Page 2: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

SPONTANEOUS ABORTION

• Definition:

Abortion is termination of pregnancy before the fetus is sufficiently developed to survive (before 24 wks)

Incidence: 15-20%

It is convenient to consider the clinical aspect of spontaneous abortion under 5 sub groups:

1. Threatened 4. Missed

2. Inevitable 5. Recurrent abortion

3. Incomplete 6. Septic Abortion

Page 3: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Threatened Abortion

• 25% of pregnancies

• This refers only to bleeding from placental site which is not yet severe enough to terminate the pregnancy.

Page 4: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

• Serial qualitative HCG level:

BHCG level – 1000 miu/ml

If gest. Sac seen & BHCG less than 1000 unlikely to survive.

Qualitative BHCG level should ↑ 65% every 48 hours.

• Serum Progesterone level

5 ng/ml associated with none viable fetus

> 25ng/ml associated with alive fetus

Expectant observation

No benefit from use of progesterone or bed rest although it is often advised.

Page 5: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Inevitable Abortion

• Indicate the pregnancy is doomed to end shortly. Progressive cervical dilation without the passage of tissue. here bleeding is slight but retroplacental

• Pain usually more.

• Dilated internal os. USS – Non viable fetus

• Emergency suction: D & C

Page 6: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Complete Abortion

• Diagnosed if patient passed tissue but now is only slight pain and P/V bleeding

• Examination confirmed closed Cx.

• Minimal current bleeding

• TVU – empty uterus

• R/O ectopic pregnancy by serial BHCG level

until P.T. -ve

• Anti D injection if patients RH – ve to prevent sensitization

Page 7: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Incomplete Abortion• If the internal cervical os is open and

patient has passed some tissue.

Management:

Emergency suction and curettage

Page 8: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Missed Abortion

• It is defined as retention of dead products of conception in utero for several weeks.

• Symptoms of early pregnancy disappear

• Uterus not only has ceased to enlarge but also has become smaller.

• Occasionally serious coagulation defect may develop.

• Abnormal sonographic findings

Page 9: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Septic Abortion

• Uterine infection at any stage of abortion causes:• Delay in evacuation of uterus

• Delay seeking advice• Incomplete surgical evacuation followed

by infection from vaginal organisms after 48 hours

Page 10: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

• Trauma:• Perforation or cervical tear• Criminal abortion

• Treatment:• Should be active to minimize risk of

septic shock• Cervical & HVS, blood culture• Broad spectrum antibiotic• Evacuation

Page 11: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Induced Abortion

• Therapeutic abortion – termination of pregnancy before the viability for the purpose of saving the life of the mother. Heart disease, invasive Ca of Cx.

• Elective (voluntary) abortion is the interruption of pregnancy before viability at request of the women but not for reason of maternal health or fetal disease.

Page 12: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Illegal abortion usually performed in unsterile condition by operators with little or nor medical training.

It is often incomplete and complicated by:

• Hemorrhage

• Infection

• Infertility and tubal occlusions

• Intrauterine infection is frequent complication and septic shock and death are the ultimate consequences.

Page 13: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Recurrent Miscarriage

• When a woman has had 3 consecutive miscarriage.

• Risk of abortion for next pregnancy:• 1 abortion 15%• 1 Normal pregnancy 15%• 1 Abortion• 1 Normal 25%• 2 Abortion• 2 abortion 40%

Page 14: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Etiology and Investigation:1. Genetic factors

Karyotyping of both partners will reveal chromosome anomalies

2. Anatomical factorsUterine anomaliesCervical incompetenceHysteroscopy & HSG – Septum / Fibroid

• Endocrine problem

• Immunological factorsCommon in women with antiphopholipid antibodies syndrome, Anticardiolipid ant. & Lupus anticoagulant

• Maternal diseaseSLE, Renal disease

• Environmental factorSmoking / Alcohol

Page 15: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Abortion Technique

Medical

Surgical

Page 16: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Ectopic Pregnancy

Page 17: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Epidemiology• Leading cause of pregnancy-related deaths

during T-1

• 1-2% of all diagnosed pregnancies

• Incidence is • incidence of salpingitis d/t chlamydia or other STI• Improved diagnostic techniques• age

• Most occur in multigravid women • > 50% in women with 3 pregnancies

• 10-15% in nulligravid women

Page 18: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Mortality

• Causes 15% of maternal deaths

• Overall risk of death 10X > the risk of childbirth; 50X > risk of legal abortion

• Cause of death r/t blood loss (80%), infection (3%), & anesthesia (2%)

• Interstitial & abdominal 5X > risk of death than other sites

Page 19: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Fallopian Tube Function

• Complex structure • sustains & transports sperm, ovum & early conceptus

for ~ 3 days• Beating cilia & rhythmic contraction of smooth

muscle neg pressure in tube• Zygote undergoes cleavage & held for another 30

hrs. in the ampullary-isthmic region• Developing blastocyst is then transported via the

isthmus into the uterus

Page 20: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Types of EP

Page 21: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Sites of EP

Fallopian tubeFallopian tube

AmpullaAmpulla 80%80%

IsthmusIsthmus 12%12%

Fimbrial endFimbrial end 5%5%

Cornual & interstitialCornual & interstitial 2%2%

AbdominalAbdominal 1.4%1.4%

OvarianOvarian 0.2%0.2%

CervicalCervical 0.2%0.2%

Heterotopic Pregnancies: 1 in 30 000

Page 22: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Risk Factors for EP

• Definite• PID• Previous EP• Any tubal surgery or sterilization procedure• infertility

Page 23: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Risk Factors for EP

• Probable• Any pelvic surgery• Use of reproductive techniques

• In vitro fertilization• Gamete intrafallopian transfer• Embryo transfer

• Uncertain Association• IUCD• “Superovulating agents”

• Pergonal, Clomiphene citrate

Page 24: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Classic TRIAD of EP

1. Delayed menses

2. Irregular vaginal bleeding

3. Abdominal pain

Page 25: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Symptoms of Ectopic Pregnancy

SYMPTOMSYMPTOM PTS WITH PTS WITH SYMPTOMSYMPTOM

Abdominal painAbdominal pain 90-100%90-100%

AmenorrheaAmenorrhea 75-95%75-95%

Vaginal bleedingVaginal bleeding 50-80%50-80%

Dizzininess, faintingDizzininess, fainting 20-35%20-35%

Pregnancy symptomsPregnancy symptoms 10-25%10-25%

Urge to defecateUrge to defecate 5-15%5-15%

Passage of tissuePassage of tissue 5-10%5-10%

Page 26: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Signs of EP

SIGNSIGN PTS WITH SIGNPTS WITH SIGN

Adnexal tendernessAdnexal tenderness 75-90%75-90%

Abdominal tendernessAbdominal tenderness 80-95%80-95%

Adnexal mass*Adnexal mass* 50%50%

Uterine enlargementUterine enlargement 20-30%20-30%

Orthostatic changesOrthostatic changes 10-15%10-15%

FeverFever 5-10%5-10%

* 20% of masses occur on the side opposite the EP.

Page 27: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Differential Diagnosis• Complication of IUP

• Abortion• Early pregnancy plus uterine fibroid or ovarian tumour

• Conditions causing acute abd pain• Torsion of ovarian tumour, FT, or subserous pedunculated

fibroid• Salpingo-oophoritis• Pelvic pain with an IUCD in situ• Appendicitis

Page 28: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Differential Dx – cont’d

• Conditions causing hemoperitoneum• Ruptured corpus luteum• Ruptured follicular cyst• Ruptured endometriotic cyst

• Conditions simulating a pelvic hematoma• Retroverted gravid uterus• Pelvic or tubo-ovarian abcess

Page 29: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Management of EP

• Pre-operative diagnostic accuracy of EP based on clinical features alone is notoriously poor: ~50%

• 20% of EP occur as surgical emergencies

• Delay is justified only to correct shock

Page 30: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Acute Management of EP

• Remember your ABCs• Oxygen• Large bore IV(s) crystalloids• Blood

• Labs• CBC, coagulation studies• -hCG

Page 31: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Usefulness of Quantitaive

-hCG• Assessment of pregnancy viability

• Serial rise usually indicates a normal pregnancy

• Correlation with ultrasonography• With titers > 1500 IU/L, TVUS should ID an IUP• With multiple gestation, a gestational sac will not be

apparent until titer rises a little higher

• Assessment of treatment results• Declining levels are c/w effective medical or surgical Tx; if

levels persist think GTD

Page 32: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

The Importance of TVUS

• Documentation of an intrauterine sac• A viable IUP should be identified when -hCG

> 1500 IU/ml

• Adnexal mass• An EP > 2 cm should be identified

• Adnexal cardiac activity• Detectable when -hCG is ~ 15 000 – 20

000

Page 33: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

U/S – Is it EP or miscarriage?

Page 34: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Surgical Management of EP

• Radical• Salpingectomy

• Conservative• Salpingotomy • Salpingostomy or segmental resection does not

repeat EP rate • fimbrial evacuation (traumatizes the endosalphinx & is

assoc with rate of recurrent EP (24%) compared with salpingectomy

Page 35: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Medical Management of EP

Methotrexate (MTX)• 1st used in Japan in 1982

• Antimetabolite that interferes with dihydrofolate reductase

• Considered for low -hCG

• Success rate 67%-94%

• Indications• Hemodynamically stable pt • good F/U• Recurrent EP following Sx intervention

Page 36: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Methotrexate – cont’d

• Contraindications• Evidence of rupture• Serum -hCG > 5 000 IU/L (varies)• FH detected on U/S• Adnexal mass> 3.5 cm on U/S• Unreliable pt• F/U unavailable• Laparoscopy required to make dx• Solid adnexal masses (germ cell tumour)• Free fluid > 30ml

Page 37: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Methotrexate Protocol

• Exclude contraindications as well as• No evidence of renal, liver, or hematopoietic disease

(Bilirubin, AST,ALT, urea, Cr, CBC)

• Informed consent• 5% risk of hematoperitoneum 2° to rupture of EP

following MTX

• MTX 50mg/m² body surface area (~1mg/kg) given IV or IM

Page 38: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Methotrexate Protocol – cont’d

• Pt F/U • repeat serum quantitative -hCG in 3-4 days,

7days, then weekly until < 10 IU/L• If > day-4 level at day-7 repeat MTX• If -hCG fails to fall by at least 25%/week at any

time repeat dose• U/S not required routinely

• Pt should avoid• Alcohol use, sexual I/C, oral folic acid (until HCG

levels are neg)

Page 39: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Methotrexate Protocol – cont’d

• What to expect• Majority experience some degree of abd pain

(occurs in ~ 50% at day-6)• Shedding of a decidual cast• Moderate vaginal bleeding

• Side effects (usually at higher doses)• Impaired liver function, bone marrow suppression,

neutropenia, stomatitis, hematosalpinx

Page 40: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Expectant Mx of EP

• Anticipates spontaneous regression of EP• Occurs in ~ 57%• Symptoms, HCG titers, & U/S findings followed• Risk of tubal rupture is 10% if HCG levels < 1000

• Criteria include• Sonographic diameter < 3cm• Initial -hCG < 1 000 IU/ml, no in 2-day period,

subsequent levels • asymptomatic

Page 41: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Future Fertility following EP

• Subsequent conception rate is ~ 60%

• Incidence of recurrent EP is 15%

• Other factors influencing include:• Age, parity, history of infertility, evidence of

contralateral tubal disease, ruptured EP, IUCD use, salpingitis

• No difference b/t laparoscopy vs laparotomy

Page 42: Emad R. Sagr, MBBS, FRCSC, FACOG Consultant OB-Gyn and Gynecology Oncology

Prevention of EP

• Treat salpingitis early & correctly

• MTX management lowers rate of subsequent EP

• Risk of EP is with all methods of contraception, except progesterone containing IUCDs

• Remember Rh Sensitization• Rhogam for the Rh-neg woman